Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
doi:10.1378/chest.07-1378
(Chest. 2007; 132:234S-242)
© 2007 American College of Chest Physicians
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, W. J.
Right arrow Articles by Pisters, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, W. J.
Right arrow Articles by Pisters, K.

Treatment of Non-small Cell Lung Cancer Stage I and Stage II*

ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)

Walter J. Scott, MD, FCCP; John Howington, MD, FCCP; Steven Feigenberg, MD; Benjamin Movsas, MD and Katherine Pisters, MD

* From the Department of Surgical Oncology, Division of Thoracic Surgery (Dr. Scott), and the Department of Radiation Oncology (Dr. Feigenberg), Fox Chase Cancer Center, Philadelphia, PA; Department of Surgery (Dr. Howington), Division of Thoracic Surgery, University of Cincinnati Medical Center, Cincinnati, OH; Department of Radiation Oncology (Dr. Movsas), Henry Ford Hospital, Detroit, MI; and the Department of Thoracic/Head & Neck Oncology (Dr. Pisters), MD Anderson Cancer Center, Houston, TX.

Correspondence to: Walter J. Scott, MD, FCCP, Fox Chase Cancer Center Suite C-312, 333 Cottman Ave, Philadelphia, PA 19111; e-mail: w_scott{at}fccc.edu

Background: The surgical treatment of stage I and II non-small cell lung cancer (NSCLC) continues to evolve in the areas of intraoperative lymph node staging (specifically the issue of lymph node dissection vs sampling), the role of sublobar resections instead of lobectomy for treatment of smaller tumors, and the use of video-assisted techniques to perform anatomic lobectomy. Adjuvant therapy (both chemotherapy and radiation therapy) and the use of larger fractions of radiotherapy delivered to a smaller area for nonoperative treatment of early stage NSCLC have shown promising results.

Methods: The panel selected the following areas for review based on clinical relevance and the amount and quality of data available for analysis: surgical approaches to resecting early stage NSCLC, methods of lymph node staging at the time of surgical resection, adjuvant chemotherapy in the treatment of early stage NSCLC, and the use of radiation therapy for primary treatment of early stage NSCLC as well as in the adjuvant setting. Recommendations by the multidisciplinary writing committee were based on literature review using established methods.

Results and conclusions: Surgical resection remains the treatment of choice for stage I and II NSCLC, although surgical methods continue to evolve. Adjuvant chemotherapy for patients with stage II, but not stage I, NSCLC is well established. Radiotherapy remains an important treatment for either cases of early stage NSCLC that are medically inoperable or patients who refuse surgery.

Key Words: ablative therapy • adjuvant therapy • chemotherapy • metaanalyses • non-small cell lung cancer • radiotherapy • stage I and II • surgery • video-assisted thoracic surgery






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Chest Physicians.